Ultragenyx Pharmaceutical (RARE) Interest Coverage Ratio (2013 - 2014)
Ultragenyx Pharmaceutical (RARE) reported Interest Coverage Ratio of 187.14 for Q2 2014, down 821.28% year-over-year from 25.95 in Q2 2013, and down 6025.08% on a QoQ basis from 3.06 in Q1 2014.
Ultragenyx Pharmaceutical (RARE) has 2 years of Interest Coverage Ratio data on file, last reported at 187.14 in Q2 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | -187.14 |
| Mar 31, 2014 | -3.06 |
| Jun 30, 2013 | -20.31 |
| Mar 31, 2013 | -481.93 |